Delivery Order SPE2DX22D0119-SPE2D826F5WPF
- Not listed
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $74,615.40 by the Defense Logistics Agency's Medical Supply Chain on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price contract was competitively awarded with no set-aside designation and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order under Amerisourcebergen's...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $30,977.72 on January 7, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside contract has a completion date of January 8, 2026, with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. The delivery order represents a task order issued under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $359,118.63 by the Defense Logistics Agency's Medical Supply Chain on January 13, 2026, with an ultimate completion date of January 14, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order under Amerisourcebergen's...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $27,807 by the Defense Logistics Agency's Medical Supply Chain on January 15, 2026, with an ultimate completion date of January 16, 2026. This firm fixed-price contract, which carries no set-aside designation, represents a task order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. The work will be performed at the company's corporate office in Conshohocken,...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $134,528.10 by the Defense Logistics Agency Medical Supply Chain on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price contract was competitively awarded without any set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a task order issued under Amerisourcebergen's...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $31,173.60 by the Defense Logistics Agency's Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under Amerisourcebergen's...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $10,618.14 by the Defense Logistics Agency's Medical Supply Chain on January 19, 2026, with an ultimate completion date of January 20, 2026. This firm fixed-price contract, issued without set-aside designation, is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order under Amerisourcebergen's larger Indefinite Delivery...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $177,236.73 by the Defense Logistics Agency's Medical Supply Chain on January 16, 2026, with an ultimate completion date of January 20, 2026. This firm fixed-price, non-set-aside contract is performed at the awardee's corporate office in Conshohocken, Pennsylvania. The delivery order falls under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $193,378.68 by the Defense Logistics Agency's Medical Supply Chain on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price contract, which carries no set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supply fulfillment. The work will be performed at the company's corporate office location in Conshohocken,...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a firm fixed-price delivery order valued at $54,074.44 by the Defense Logistics Agency's Medical Supply Chain on January 19, 2026, with an ultimate completion date of January 20, 2026. This non-set-aside contract is performed at the company's Conshohocken, Pennsylvania location. The delivery order represents work executed under Amerisourcebergen's broader Indefinite Delivery Contract with DLA Troop Support Medical, a...
- SPE2DX22D0119Indefinite Delivery Contract
- SPE2DX22D0119-SPE2D826F5WPFDelivery Order
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $33,813.45 by the Defense Logistics Agency Medical Supply Chain on January 16, 2026, with an ultimate completion date of January 20, 2026. The contract is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. This award represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $1 billion through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and healthcare solutions provider, Amerisourcebergen Drug Corp supplies critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contracting history demonstrates consistent capability to meet competitive procurement requirements across a wide spectrum of pharmaceutical products and delivery models, ranging from small-value transactions to substantial orders exceeding $45,000, reinforcing its role as a critical vendor for federal military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $33.8k | 1/15/26 |